Afuco™ Anti-CD276 ADCC Recombinant Antibody (Enoblituzumab), ADCC Enhanced (CAT#: AFC-TAB-424CQ)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD276. Enoblituzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Solid tumors.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • ADCC enhanced antibody
  • Specificity
  • Human CD276
  • Species Reactivity
  • Human
  • Clone
  • Enoblituzumab
  • Applications
  • ELISA, IHC, FC, IP, IF, FuncS
  • Conjugate
  • Unconjugated
  • Generic Name
  • Enoblituzumab
  • Related Disease
  • Solid tumors

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • CD276 Molecule; Costimulatory Molecule; CD276 Antigen; B7 Homolog 3; 4Ig-B7-H3; B7-H3; B7H3; B7RP-2

Related Resources

  • Biosimilar Overview
Please refer to Enoblituzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Enoblituzumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Enoblituzumab"

Anti-Human CD276 Recombinant Antibody (Enoblituzumab)
Recombinant monoclonal antibody to CD276. Enoblituzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Solid tumors.

See other products for "CD276"

Humanized Antibody

CAT Product Name Application Type
TAB-117CL Anti-Human CD276 Recombinant Antibody (MGA271) ADCC, FuncS Antibody
TAB-424CQ Anti-Human CD276 Recombinant Antibody (Enoblituzumab) ELISA, IHC, FC, IP, IF, FuncS IgG1, κ

Blocking Antibody

CAT Product Name Application Type
NEUT-333CQ Rat Anti-CD276 Recombinant Antibody (clone MJ18) Block, FC Rat IgG1

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-0549 Hi-Affi™ Rabbit Anti-CD276 Recombinant Antibody (clone DS549AB) WB, IP, FC Rabbit IgG

Recombinant Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-424CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare